Global AI Drug Discovery Supply, Demand and Key Producers, 2026-2032
The global AI Drug Discovery market size is expected to reach $ 47759 million by 2032, rising at a market growth of 29.2% CAGR during the forecast period (2026-2032).
AI Drug Discovery refers to the use of artificial intelligence (AI) technologies, machine learning (ML) algorithms, and big data analysis to accelerate drug discovery, design, screening, and optimization. The core advantage of AI drug discovery lies in its high data processing and pattern recognition capabilities, which can help identify potential drug candidates, predict biological activities, optimize preclinical drug effects, and shorten the drug development cycle. Common applications in AI drug discovery include target discovery, virtual screening, drug repurposing, molecular design, and clinical data analysis.
The upstream of the industry chain involves data resources and algorithm technologies, such as genomic data, protein structure databases, chemical libraries, and AI platforms. Downstream applications are concentrated in pharmaceutical companies, new drug R&D institutions, and contract research organizations (CROs), supporting drug discovery, target validation, drug repositioning, and personalized medicine design. Pharmaceutical companies leverage AI to shorten development cycles, reduce costs, and improve drug success rates. CROs utilize AI for compound screening, toxicity prediction, and clinical trial design, enhancing overall R&D efficiency.
Development trends include multimodal data integration, generative AI for drug design, AI-assisted clinical trial optimization, and precision medicine integration. Driving factors include high costs of traditional drug development, long R&D timelines, high clinical failure rates, and enhanced AI computational capabilities. Constraints include difficulty in acquiring high-quality data, limited algorithm interpretability, regulatory uncertainties, and shortage of specialized talent. Overall industry gross margins are relatively high, typically ranging from 40% to 60%, driven by the added value of software and AI services to pharmaceutical companies and technological barriers.
This report studies the global AI Drug Discovery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Discovery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Discovery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Discovery total market, 2021-2032, (USD Million)
Global AI Drug Discovery total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Drug Discovery total market, key domestic companies, and share, (USD Million)
Global AI Drug Discovery revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Drug Discovery total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Drug Discovery total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recursion, Insilico Medicine, Schr?dinger, DeepMind, Insitro, Generate Biomedicines, XtalPi, Relay Therapeutics, BenevolentAI, Roivant Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Drug Discovery market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Drug Discovery Market, By Region:
1. How big is the global AI Drug Discovery market?
2. What is the demand of the global AI Drug Discovery market?
3. What is the year over year growth of the global AI Drug Discovery market?
4. What is the total value of the global AI Drug Discovery market?
5. Who are the Major Players in the global AI Drug Discovery market?
6. What are the growth factors driving the market demand?
AI Drug Discovery refers to the use of artificial intelligence (AI) technologies, machine learning (ML) algorithms, and big data analysis to accelerate drug discovery, design, screening, and optimization. The core advantage of AI drug discovery lies in its high data processing and pattern recognition capabilities, which can help identify potential drug candidates, predict biological activities, optimize preclinical drug effects, and shorten the drug development cycle. Common applications in AI drug discovery include target discovery, virtual screening, drug repurposing, molecular design, and clinical data analysis.
The upstream of the industry chain involves data resources and algorithm technologies, such as genomic data, protein structure databases, chemical libraries, and AI platforms. Downstream applications are concentrated in pharmaceutical companies, new drug R&D institutions, and contract research organizations (CROs), supporting drug discovery, target validation, drug repositioning, and personalized medicine design. Pharmaceutical companies leverage AI to shorten development cycles, reduce costs, and improve drug success rates. CROs utilize AI for compound screening, toxicity prediction, and clinical trial design, enhancing overall R&D efficiency.
Development trends include multimodal data integration, generative AI for drug design, AI-assisted clinical trial optimization, and precision medicine integration. Driving factors include high costs of traditional drug development, long R&D timelines, high clinical failure rates, and enhanced AI computational capabilities. Constraints include difficulty in acquiring high-quality data, limited algorithm interpretability, regulatory uncertainties, and shortage of specialized talent. Overall industry gross margins are relatively high, typically ranging from 40% to 60%, driven by the added value of software and AI services to pharmaceutical companies and technological barriers.
This report studies the global AI Drug Discovery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Discovery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Discovery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Discovery total market, 2021-2032, (USD Million)
Global AI Drug Discovery total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Drug Discovery total market, key domestic companies, and share, (USD Million)
Global AI Drug Discovery revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Drug Discovery total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Drug Discovery total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recursion, Insilico Medicine, Schr?dinger, DeepMind, Insitro, Generate Biomedicines, XtalPi, Relay Therapeutics, BenevolentAI, Roivant Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Drug Discovery market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Drug Discovery Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Machine Learning Type
- Deep Learning Type
- Natural Language Processing Type
- Data Mining Type
- Small Molecule Drugs
- Biomacromolecules
- Novel Therapies
- High-Performance Computing Type
- Cloud Computing Type
- Edge Computing Type
- Target Discovery and Validation
- Virtual Screening and Molecular Docking
- Drug Repurposing and Precision Medicine
- Clinical Data Analysis and Optimization
- Recursion
- Insilico Medicine
- Schr?dinger
- DeepMind
- Insitro
- Generate Biomedicines
- XtalPi
- Relay Therapeutics
- BenevolentAI
- Roivant Sciences
- Ginkgo Bioworks
- Exscientia
- Merck KGaA
- Novartis
- Biotus
- Huazhi Bio
- MindRank AI
- Ubigene
- WuXi AppTec
1. How big is the global AI Drug Discovery market?
2. What is the demand of the global AI Drug Discovery market?
3. What is the year over year growth of the global AI Drug Discovery market?
4. What is the total value of the global AI Drug Discovery market?
5. Who are the Major Players in the global AI Drug Discovery market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI Drug Discovery Introduction
1.2 World AI Drug Discovery Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Drug Discovery Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Discovery Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Drug Discovery Revenue (2021-2032)
1.3.3 China Based Company AI Drug Discovery Revenue (2021-2032)
1.3.4 Europe Based Company AI Drug Discovery Revenue (2021-2032)
1.3.5 Japan Based Company AI Drug Discovery Revenue (2021-2032)
1.3.6 South Korea Based Company AI Drug Discovery Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Drug Discovery Revenue (2021-2032)
1.3.8 India Based Company AI Drug Discovery Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Discovery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Drug Discovery Consumption Value (2021-2032)
2.2 World AI Drug Discovery Consumption Value by Region
2.2.1 World AI Drug Discovery Consumption Value by Region (2021-2026)
2.2.2 World AI Drug Discovery Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Drug Discovery Consumption Value (2021-2032)
2.4 China AI Drug Discovery Consumption Value (2021-2032)
2.5 Europe AI Drug Discovery Consumption Value (2021-2032)
2.6 Japan AI Drug Discovery Consumption Value (2021-2032)
2.7 South Korea AI Drug Discovery Consumption Value (2021-2032)
2.8 ASEAN AI Drug Discovery Consumption Value (2021-2032)
2.9 India AI Drug Discovery Consumption Value (2021-2032)
3 WORLD AI DRUG DISCOVERY COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Discovery Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Discovery Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Discovery in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Drug Discovery in 2025
3.3 AI Drug Discovery Company Evaluation Quadrant
3.4 AI Drug Discovery Market: Overall Company Footprint Analysis
3.4.1 AI Drug Discovery Market: Region Footprint
3.4.2 AI Drug Discovery Market: Company Product Type Footprint
3.4.3 AI Drug Discovery Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Discovery Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Discovery Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Discovery Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Drug Discovery Consumption Value Comparison
4.2.1 United States VS China: AI Drug Discovery Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Drug Discovery Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Drug Discovery Companies and Market Share, 2021-2026
4.3.1 United States Based AI Drug Discovery Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Discovery Revenue, (2021-2026)
4.4 China Based Companies AI Drug Discovery Revenue and Market Share, 2021-2026
4.4.1 China Based AI Drug Discovery Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Discovery Revenue, (2021-2026)
4.5 Rest of World Based AI Drug Discovery Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Drug Discovery Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Drug Discovery Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Discovery Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Machine Learning Type
5.2.2 Deep Learning Type
5.2.3 Natural Language Processing Type
5.2.4 Data Mining Type
5.3 Market Segment by Type
5.3.1 World AI Drug Discovery Market Size by Type (2021-2026)
5.3.2 World AI Drug Discovery Market Size by Type (2027-2032)
5.3.3 World AI Drug Discovery Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DRUG TYPE
6.1 World AI Drug Discovery Market Size Overview by Drug Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Drug Type
6.2.1 Small Molecule Drugs
6.2.2 Biomacromolecules
6.2.3 Novel Therapies
6.3 Market Segment by Drug Type
6.3.1 World AI Drug Discovery Market Size by Drug Type (2021-2026)
6.3.2 World AI Drug Discovery Market Size by Drug Type (2027-2032)
6.3.3 World AI Drug Discovery Market Size Market Share by Drug Type (2027-2032)
7 MARKET ANALYSIS BY COMPUTATIONAL POWER
7.1 World AI Drug Discovery Market Size Overview by Computational Power: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Computational Power
7.2.1 High-Performance Computing Type
7.2.2 Cloud Computing Type
7.2.3 Edge Computing Type
7.3 Market Segment by Computational Power
7.3.1 World AI Drug Discovery Market Size by Computational Power (2021-2026)
7.3.2 World AI Drug Discovery Market Size by Computational Power (2027-2032)
7.3.3 World AI Drug Discovery Market Size Market Share by Computational Power (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI Drug Discovery Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Target Discovery and Validation
8.2.2 Virtual Screening and Molecular Docking
8.2.3 Drug Repurposing and Precision Medicine
8.2.4 Clinical Data Analysis and Optimization
8.3 Market Segment by Application
8.3.1 World AI Drug Discovery Market Size by Application (2021-2026)
8.3.2 World AI Drug Discovery Market Size by Application (2027-2032)
8.3.3 World AI Drug Discovery Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Recursion
9.1.1 Recursion Details
9.1.2 Recursion Major Business
9.1.3 Recursion AI Drug Discovery Product and Services
9.1.4 Recursion AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Recursion Recent Developments/Updates
9.1.6 Recursion Competitive Strengths & Weaknesses
9.2 Insilico Medicine
9.2.1 Insilico Medicine Details
9.2.2 Insilico Medicine Major Business
9.2.3 Insilico Medicine AI Drug Discovery Product and Services
9.2.4 Insilico Medicine AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Insilico Medicine Recent Developments/Updates
9.2.6 Insilico Medicine Competitive Strengths & Weaknesses
9.3 Schr?dinger
9.3.1 Schr?dinger Details
9.3.2 Schr?dinger Major Business
9.3.3 Schr?dinger AI Drug Discovery Product and Services
9.3.4 Schr?dinger AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Schr?dinger Recent Developments/Updates
9.3.6 Schr?dinger Competitive Strengths & Weaknesses
9.4 DeepMind
9.4.1 DeepMind Details
9.4.2 DeepMind Major Business
9.4.3 DeepMind AI Drug Discovery Product and Services
9.4.4 DeepMind AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 DeepMind Recent Developments/Updates
9.4.6 DeepMind Competitive Strengths & Weaknesses
9.5 Insitro
9.5.1 Insitro Details
9.5.2 Insitro Major Business
9.5.3 Insitro AI Drug Discovery Product and Services
9.5.4 Insitro AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Insitro Recent Developments/Updates
9.5.6 Insitro Competitive Strengths & Weaknesses
9.6 Generate Biomedicines
9.6.1 Generate Biomedicines Details
9.6.2 Generate Biomedicines Major Business
9.6.3 Generate Biomedicines AI Drug Discovery Product and Services
9.6.4 Generate Biomedicines AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Generate Biomedicines Recent Developments/Updates
9.6.6 Generate Biomedicines Competitive Strengths & Weaknesses
9.7 XtalPi
9.7.1 XtalPi Details
9.7.2 XtalPi Major Business
9.7.3 XtalPi AI Drug Discovery Product and Services
9.7.4 XtalPi AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 XtalPi Recent Developments/Updates
9.7.6 XtalPi Competitive Strengths & Weaknesses
9.8 Relay Therapeutics
9.8.1 Relay Therapeutics Details
9.8.2 Relay Therapeutics Major Business
9.8.3 Relay Therapeutics AI Drug Discovery Product and Services
9.8.4 Relay Therapeutics AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Relay Therapeutics Recent Developments/Updates
9.8.6 Relay Therapeutics Competitive Strengths & Weaknesses
9.9 BenevolentAI
9.9.1 BenevolentAI Details
9.9.2 BenevolentAI Major Business
9.9.3 BenevolentAI AI Drug Discovery Product and Services
9.9.4 BenevolentAI AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 BenevolentAI Recent Developments/Updates
9.9.6 BenevolentAI Competitive Strengths & Weaknesses
9.10 Roivant Sciences
9.10.1 Roivant Sciences Details
9.10.2 Roivant Sciences Major Business
9.10.3 Roivant Sciences AI Drug Discovery Product and Services
9.10.4 Roivant Sciences AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Roivant Sciences Recent Developments/Updates
9.10.6 Roivant Sciences Competitive Strengths & Weaknesses
9.11 Ginkgo Bioworks
9.11.1 Ginkgo Bioworks Details
9.11.2 Ginkgo Bioworks Major Business
9.11.3 Ginkgo Bioworks AI Drug Discovery Product and Services
9.11.4 Ginkgo Bioworks AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Ginkgo Bioworks Recent Developments/Updates
9.11.6 Ginkgo Bioworks Competitive Strengths & Weaknesses
9.12 Exscientia
9.12.1 Exscientia Details
9.12.2 Exscientia Major Business
9.12.3 Exscientia AI Drug Discovery Product and Services
9.12.4 Exscientia AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Exscientia Recent Developments/Updates
9.12.6 Exscientia Competitive Strengths & Weaknesses
9.13 Merck KGaA
9.13.1 Merck KGaA Details
9.13.2 Merck KGaA Major Business
9.13.3 Merck KGaA AI Drug Discovery Product and Services
9.13.4 Merck KGaA AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Merck KGaA Recent Developments/Updates
9.13.6 Merck KGaA Competitive Strengths & Weaknesses
9.14 Novartis
9.14.1 Novartis Details
9.14.2 Novartis Major Business
9.14.3 Novartis AI Drug Discovery Product and Services
9.14.4 Novartis AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Novartis Recent Developments/Updates
9.14.6 Novartis Competitive Strengths & Weaknesses
9.15 Biotus
9.15.1 Biotus Details
9.15.2 Biotus Major Business
9.15.3 Biotus AI Drug Discovery Product and Services
9.15.4 Biotus AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Biotus Recent Developments/Updates
9.15.6 Biotus Competitive Strengths & Weaknesses
9.16 Huazhi Bio
9.16.1 Huazhi Bio Details
9.16.2 Huazhi Bio Major Business
9.16.3 Huazhi Bio AI Drug Discovery Product and Services
9.16.4 Huazhi Bio AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Huazhi Bio Recent Developments/Updates
9.16.6 Huazhi Bio Competitive Strengths & Weaknesses
9.17 MindRank AI
9.17.1 MindRank AI Details
9.17.2 MindRank AI Major Business
9.17.3 MindRank AI AI Drug Discovery Product and Services
9.17.4 MindRank AI AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 MindRank AI Recent Developments/Updates
9.17.6 MindRank AI Competitive Strengths & Weaknesses
9.18 Ubigene
9.18.1 Ubigene Details
9.18.2 Ubigene Major Business
9.18.3 Ubigene AI Drug Discovery Product and Services
9.18.4 Ubigene AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Ubigene Recent Developments/Updates
9.18.6 Ubigene Competitive Strengths & Weaknesses
9.19 WuXi AppTec
9.19.1 WuXi AppTec Details
9.19.2 WuXi AppTec Major Business
9.19.3 WuXi AppTec AI Drug Discovery Product and Services
9.19.4 WuXi AppTec AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 WuXi AppTec Recent Developments/Updates
9.19.6 WuXi AppTec Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI Drug Discovery Industry Chain
10.2 AI Drug Discovery Upstream Analysis
10.3 AI Drug Discovery Midstream Analysis
10.4 AI Drug Discovery Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 AI Drug Discovery Introduction
1.2 World AI Drug Discovery Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Drug Discovery Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Discovery Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Drug Discovery Revenue (2021-2032)
1.3.3 China Based Company AI Drug Discovery Revenue (2021-2032)
1.3.4 Europe Based Company AI Drug Discovery Revenue (2021-2032)
1.3.5 Japan Based Company AI Drug Discovery Revenue (2021-2032)
1.3.6 South Korea Based Company AI Drug Discovery Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Drug Discovery Revenue (2021-2032)
1.3.8 India Based Company AI Drug Discovery Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Discovery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Drug Discovery Consumption Value (2021-2032)
2.2 World AI Drug Discovery Consumption Value by Region
2.2.1 World AI Drug Discovery Consumption Value by Region (2021-2026)
2.2.2 World AI Drug Discovery Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Drug Discovery Consumption Value (2021-2032)
2.4 China AI Drug Discovery Consumption Value (2021-2032)
2.5 Europe AI Drug Discovery Consumption Value (2021-2032)
2.6 Japan AI Drug Discovery Consumption Value (2021-2032)
2.7 South Korea AI Drug Discovery Consumption Value (2021-2032)
2.8 ASEAN AI Drug Discovery Consumption Value (2021-2032)
2.9 India AI Drug Discovery Consumption Value (2021-2032)
3 WORLD AI DRUG DISCOVERY COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Discovery Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Discovery Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Discovery in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Drug Discovery in 2025
3.3 AI Drug Discovery Company Evaluation Quadrant
3.4 AI Drug Discovery Market: Overall Company Footprint Analysis
3.4.1 AI Drug Discovery Market: Region Footprint
3.4.2 AI Drug Discovery Market: Company Product Type Footprint
3.4.3 AI Drug Discovery Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Discovery Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Discovery Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Discovery Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Drug Discovery Consumption Value Comparison
4.2.1 United States VS China: AI Drug Discovery Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Drug Discovery Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Drug Discovery Companies and Market Share, 2021-2026
4.3.1 United States Based AI Drug Discovery Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Discovery Revenue, (2021-2026)
4.4 China Based Companies AI Drug Discovery Revenue and Market Share, 2021-2026
4.4.1 China Based AI Drug Discovery Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Discovery Revenue, (2021-2026)
4.5 Rest of World Based AI Drug Discovery Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Drug Discovery Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Drug Discovery Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Discovery Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Machine Learning Type
5.2.2 Deep Learning Type
5.2.3 Natural Language Processing Type
5.2.4 Data Mining Type
5.3 Market Segment by Type
5.3.1 World AI Drug Discovery Market Size by Type (2021-2026)
5.3.2 World AI Drug Discovery Market Size by Type (2027-2032)
5.3.3 World AI Drug Discovery Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DRUG TYPE
6.1 World AI Drug Discovery Market Size Overview by Drug Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Drug Type
6.2.1 Small Molecule Drugs
6.2.2 Biomacromolecules
6.2.3 Novel Therapies
6.3 Market Segment by Drug Type
6.3.1 World AI Drug Discovery Market Size by Drug Type (2021-2026)
6.3.2 World AI Drug Discovery Market Size by Drug Type (2027-2032)
6.3.3 World AI Drug Discovery Market Size Market Share by Drug Type (2027-2032)
7 MARKET ANALYSIS BY COMPUTATIONAL POWER
7.1 World AI Drug Discovery Market Size Overview by Computational Power: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Computational Power
7.2.1 High-Performance Computing Type
7.2.2 Cloud Computing Type
7.2.3 Edge Computing Type
7.3 Market Segment by Computational Power
7.3.1 World AI Drug Discovery Market Size by Computational Power (2021-2026)
7.3.2 World AI Drug Discovery Market Size by Computational Power (2027-2032)
7.3.3 World AI Drug Discovery Market Size Market Share by Computational Power (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI Drug Discovery Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Target Discovery and Validation
8.2.2 Virtual Screening and Molecular Docking
8.2.3 Drug Repurposing and Precision Medicine
8.2.4 Clinical Data Analysis and Optimization
8.3 Market Segment by Application
8.3.1 World AI Drug Discovery Market Size by Application (2021-2026)
8.3.2 World AI Drug Discovery Market Size by Application (2027-2032)
8.3.3 World AI Drug Discovery Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Recursion
9.1.1 Recursion Details
9.1.2 Recursion Major Business
9.1.3 Recursion AI Drug Discovery Product and Services
9.1.4 Recursion AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Recursion Recent Developments/Updates
9.1.6 Recursion Competitive Strengths & Weaknesses
9.2 Insilico Medicine
9.2.1 Insilico Medicine Details
9.2.2 Insilico Medicine Major Business
9.2.3 Insilico Medicine AI Drug Discovery Product and Services
9.2.4 Insilico Medicine AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Insilico Medicine Recent Developments/Updates
9.2.6 Insilico Medicine Competitive Strengths & Weaknesses
9.3 Schr?dinger
9.3.1 Schr?dinger Details
9.3.2 Schr?dinger Major Business
9.3.3 Schr?dinger AI Drug Discovery Product and Services
9.3.4 Schr?dinger AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Schr?dinger Recent Developments/Updates
9.3.6 Schr?dinger Competitive Strengths & Weaknesses
9.4 DeepMind
9.4.1 DeepMind Details
9.4.2 DeepMind Major Business
9.4.3 DeepMind AI Drug Discovery Product and Services
9.4.4 DeepMind AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 DeepMind Recent Developments/Updates
9.4.6 DeepMind Competitive Strengths & Weaknesses
9.5 Insitro
9.5.1 Insitro Details
9.5.2 Insitro Major Business
9.5.3 Insitro AI Drug Discovery Product and Services
9.5.4 Insitro AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Insitro Recent Developments/Updates
9.5.6 Insitro Competitive Strengths & Weaknesses
9.6 Generate Biomedicines
9.6.1 Generate Biomedicines Details
9.6.2 Generate Biomedicines Major Business
9.6.3 Generate Biomedicines AI Drug Discovery Product and Services
9.6.4 Generate Biomedicines AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Generate Biomedicines Recent Developments/Updates
9.6.6 Generate Biomedicines Competitive Strengths & Weaknesses
9.7 XtalPi
9.7.1 XtalPi Details
9.7.2 XtalPi Major Business
9.7.3 XtalPi AI Drug Discovery Product and Services
9.7.4 XtalPi AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 XtalPi Recent Developments/Updates
9.7.6 XtalPi Competitive Strengths & Weaknesses
9.8 Relay Therapeutics
9.8.1 Relay Therapeutics Details
9.8.2 Relay Therapeutics Major Business
9.8.3 Relay Therapeutics AI Drug Discovery Product and Services
9.8.4 Relay Therapeutics AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Relay Therapeutics Recent Developments/Updates
9.8.6 Relay Therapeutics Competitive Strengths & Weaknesses
9.9 BenevolentAI
9.9.1 BenevolentAI Details
9.9.2 BenevolentAI Major Business
9.9.3 BenevolentAI AI Drug Discovery Product and Services
9.9.4 BenevolentAI AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 BenevolentAI Recent Developments/Updates
9.9.6 BenevolentAI Competitive Strengths & Weaknesses
9.10 Roivant Sciences
9.10.1 Roivant Sciences Details
9.10.2 Roivant Sciences Major Business
9.10.3 Roivant Sciences AI Drug Discovery Product and Services
9.10.4 Roivant Sciences AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Roivant Sciences Recent Developments/Updates
9.10.6 Roivant Sciences Competitive Strengths & Weaknesses
9.11 Ginkgo Bioworks
9.11.1 Ginkgo Bioworks Details
9.11.2 Ginkgo Bioworks Major Business
9.11.3 Ginkgo Bioworks AI Drug Discovery Product and Services
9.11.4 Ginkgo Bioworks AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Ginkgo Bioworks Recent Developments/Updates
9.11.6 Ginkgo Bioworks Competitive Strengths & Weaknesses
9.12 Exscientia
9.12.1 Exscientia Details
9.12.2 Exscientia Major Business
9.12.3 Exscientia AI Drug Discovery Product and Services
9.12.4 Exscientia AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Exscientia Recent Developments/Updates
9.12.6 Exscientia Competitive Strengths & Weaknesses
9.13 Merck KGaA
9.13.1 Merck KGaA Details
9.13.2 Merck KGaA Major Business
9.13.3 Merck KGaA AI Drug Discovery Product and Services
9.13.4 Merck KGaA AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Merck KGaA Recent Developments/Updates
9.13.6 Merck KGaA Competitive Strengths & Weaknesses
9.14 Novartis
9.14.1 Novartis Details
9.14.2 Novartis Major Business
9.14.3 Novartis AI Drug Discovery Product and Services
9.14.4 Novartis AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Novartis Recent Developments/Updates
9.14.6 Novartis Competitive Strengths & Weaknesses
9.15 Biotus
9.15.1 Biotus Details
9.15.2 Biotus Major Business
9.15.3 Biotus AI Drug Discovery Product and Services
9.15.4 Biotus AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Biotus Recent Developments/Updates
9.15.6 Biotus Competitive Strengths & Weaknesses
9.16 Huazhi Bio
9.16.1 Huazhi Bio Details
9.16.2 Huazhi Bio Major Business
9.16.3 Huazhi Bio AI Drug Discovery Product and Services
9.16.4 Huazhi Bio AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Huazhi Bio Recent Developments/Updates
9.16.6 Huazhi Bio Competitive Strengths & Weaknesses
9.17 MindRank AI
9.17.1 MindRank AI Details
9.17.2 MindRank AI Major Business
9.17.3 MindRank AI AI Drug Discovery Product and Services
9.17.4 MindRank AI AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 MindRank AI Recent Developments/Updates
9.17.6 MindRank AI Competitive Strengths & Weaknesses
9.18 Ubigene
9.18.1 Ubigene Details
9.18.2 Ubigene Major Business
9.18.3 Ubigene AI Drug Discovery Product and Services
9.18.4 Ubigene AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Ubigene Recent Developments/Updates
9.18.6 Ubigene Competitive Strengths & Weaknesses
9.19 WuXi AppTec
9.19.1 WuXi AppTec Details
9.19.2 WuXi AppTec Major Business
9.19.3 WuXi AppTec AI Drug Discovery Product and Services
9.19.4 WuXi AppTec AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 WuXi AppTec Recent Developments/Updates
9.19.6 WuXi AppTec Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI Drug Discovery Industry Chain
10.2 AI Drug Discovery Upstream Analysis
10.3 AI Drug Discovery Midstream Analysis
10.4 AI Drug Discovery Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World AI Drug Discovery Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Discovery Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Discovery Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Discovery Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Drug Discovery Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Discovery Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Drug Discovery Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Drug Discovery Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Drug Discovery Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Discovery Players in 2025
Table 12. World AI Drug Discovery Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Drug Discovery Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Discovery Players
Table 15. AI Drug Discovery Market: Company Product Type Footprint
Table 16. AI Drug Discovery Market: Company Product Application Footprint
Table 17. AI Drug Discovery Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Discovery Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Drug Discovery Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Drug Discovery Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Discovery Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Drug Discovery Revenue Market Share (2021-2026)
Table 23. China Based AI Drug Discovery Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Discovery Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Drug Discovery Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Drug Discovery Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Drug Discovery Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Discovery Revenue Market Share (2021-2026)
Table 29. World AI Drug Discovery Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Drug Discovery Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Drug Discovery Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Drug Discovery Market Size by Drug Type, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Drug Discovery Market Size Value by Drug Type (2021-2026) & (USD Million)
Table 34. World AI Drug Discovery Market Size by Drug Type (2027-2032) & (USD Million)
Table 35. World AI Drug Discovery Market Size by Computational Power, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Drug Discovery Market Size Value by Computational Power (2021-2026) & (USD Million)
Table 37. World AI Drug Discovery Market Size by Computational Power (2027-2032) & (USD Million)
Table 38. World AI Drug Discovery Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Drug Discovery Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI Drug Discovery Market Size by Application (2027-2032) & (USD Million)
Table 41. Recursion Basic Information, Manufacturing Base and Competitors
Table 42. Recursion Major Business
Table 43. Recursion AI Drug Discovery Product and Services
Table 44. Recursion AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Recursion Recent Developments/Updates
Table 46. Recursion Competitive Strengths & Weaknesses
Table 47. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 48. Insilico Medicine Major Business
Table 49. Insilico Medicine AI Drug Discovery Product and Services
Table 50. Insilico Medicine AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Insilico Medicine Recent Developments/Updates
Table 52. Insilico Medicine Competitive Strengths & Weaknesses
Table 53. Schr?dinger Basic Information, Manufacturing Base and Competitors
Table 54. Schr?dinger Major Business
Table 55. Schr?dinger AI Drug Discovery Product and Services
Table 56. Schr?dinger AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Schr?dinger Recent Developments/Updates
Table 58. Schr?dinger Competitive Strengths & Weaknesses
Table 59. DeepMind Basic Information, Manufacturing Base and Competitors
Table 60. DeepMind Major Business
Table 61. DeepMind AI Drug Discovery Product and Services
Table 62. DeepMind AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. DeepMind Recent Developments/Updates
Table 64. DeepMind Competitive Strengths & Weaknesses
Table 65. Insitro Basic Information, Manufacturing Base and Competitors
Table 66. Insitro Major Business
Table 67. Insitro AI Drug Discovery Product and Services
Table 68. Insitro AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Insitro Recent Developments/Updates
Table 70. Insitro Competitive Strengths & Weaknesses
Table 71. Generate Biomedicines Basic Information, Manufacturing Base and Competitors
Table 72. Generate Biomedicines Major Business
Table 73. Generate Biomedicines AI Drug Discovery Product and Services
Table 74. Generate Biomedicines AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Generate Biomedicines Recent Developments/Updates
Table 76. Generate Biomedicines Competitive Strengths & Weaknesses
Table 77. XtalPi Basic Information, Manufacturing Base and Competitors
Table 78. XtalPi Major Business
Table 79. XtalPi AI Drug Discovery Product and Services
Table 80. XtalPi AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. XtalPi Recent Developments/Updates
Table 82. XtalPi Competitive Strengths & Weaknesses
Table 83. Relay Therapeutics Basic Information, Manufacturing Base and Competitors
Table 84. Relay Therapeutics Major Business
Table 85. Relay Therapeutics AI Drug Discovery Product and Services
Table 86. Relay Therapeutics AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Relay Therapeutics Recent Developments/Updates
Table 88. Relay Therapeutics Competitive Strengths & Weaknesses
Table 89. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 90. BenevolentAI Major Business
Table 91. BenevolentAI AI Drug Discovery Product and Services
Table 92. BenevolentAI AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. BenevolentAI Recent Developments/Updates
Table 94. BenevolentAI Competitive Strengths & Weaknesses
Table 95. Roivant Sciences Basic Information, Manufacturing Base and Competitors
Table 96. Roivant Sciences Major Business
Table 97. Roivant Sciences AI Drug Discovery Product and Services
Table 98. Roivant Sciences AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Roivant Sciences Recent Developments/Updates
Table 100. Roivant Sciences Competitive Strengths & Weaknesses
Table 101. Ginkgo Bioworks Basic Information, Manufacturing Base and Competitors
Table 102. Ginkgo Bioworks Major Business
Table 103. Ginkgo Bioworks AI Drug Discovery Product and Services
Table 104. Ginkgo Bioworks AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Ginkgo Bioworks Recent Developments/Updates
Table 106. Ginkgo Bioworks Competitive Strengths & Weaknesses
Table 107. Exscientia Basic Information, Manufacturing Base and Competitors
Table 108. Exscientia Major Business
Table 109. Exscientia AI Drug Discovery Product and Services
Table 110. Exscientia AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Exscientia Recent Developments/Updates
Table 112. Exscientia Competitive Strengths & Weaknesses
Table 113. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 114. Merck KGaA Major Business
Table 115. Merck KGaA AI Drug Discovery Product and Services
Table 116. Merck KGaA AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Merck KGaA Recent Developments/Updates
Table 118. Merck KGaA Competitive Strengths & Weaknesses
Table 119. Novartis Basic Information, Manufacturing Base and Competitors
Table 120. Novartis Major Business
Table 121. Novartis AI Drug Discovery Product and Services
Table 122. Novartis AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Novartis Recent Developments/Updates
Table 124. Novartis Competitive Strengths & Weaknesses
Table 125. Biotus Basic Information, Manufacturing Base and Competitors
Table 126. Biotus Major Business
Table 127. Biotus AI Drug Discovery Product and Services
Table 128. Biotus AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Biotus Recent Developments/Updates
Table 130. Biotus Competitive Strengths & Weaknesses
Table 131. Huazhi Bio Basic Information, Manufacturing Base and Competitors
Table 132. Huazhi Bio Major Business
Table 133. Huazhi Bio AI Drug Discovery Product and Services
Table 134. Huazhi Bio AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Huazhi Bio Recent Developments/Updates
Table 136. Huazhi Bio Competitive Strengths & Weaknesses
Table 137. MindRank AI Basic Information, Manufacturing Base and Competitors
Table 138. MindRank AI Major Business
Table 139. MindRank AI AI Drug Discovery Product and Services
Table 140. MindRank AI AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. MindRank AI Recent Developments/Updates
Table 142. MindRank AI Competitive Strengths & Weaknesses
Table 143. Ubigene Basic Information, Manufacturing Base and Competitors
Table 144. Ubigene Major Business
Table 145. Ubigene AI Drug Discovery Product and Services
Table 146. Ubigene AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Ubigene Recent Developments/Updates
Table 148. Ubigene Competitive Strengths & Weaknesses
Table 149. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 150. WuXi AppTec Major Business
Table 151. WuXi AppTec AI Drug Discovery Product and Services
Table 152. WuXi AppTec AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. WuXi AppTec Recent Developments/Updates
Table 154. WuXi AppTec Competitive Strengths & Weaknesses
Table 155. Global Key Players of AI Drug Discovery Upstream (Raw Materials)
Table 156. Global AI Drug Discovery Typical Customers
Table 1. World AI Drug Discovery Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Discovery Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Discovery Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Discovery Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Drug Discovery Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Discovery Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Drug Discovery Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Drug Discovery Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Drug Discovery Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Discovery Players in 2025
Table 12. World AI Drug Discovery Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Drug Discovery Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Discovery Players
Table 15. AI Drug Discovery Market: Company Product Type Footprint
Table 16. AI Drug Discovery Market: Company Product Application Footprint
Table 17. AI Drug Discovery Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Discovery Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Drug Discovery Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Drug Discovery Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Discovery Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Drug Discovery Revenue Market Share (2021-2026)
Table 23. China Based AI Drug Discovery Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Discovery Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Drug Discovery Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Drug Discovery Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Drug Discovery Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Discovery Revenue Market Share (2021-2026)
Table 29. World AI Drug Discovery Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Drug Discovery Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Drug Discovery Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Drug Discovery Market Size by Drug Type, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Drug Discovery Market Size Value by Drug Type (2021-2026) & (USD Million)
Table 34. World AI Drug Discovery Market Size by Drug Type (2027-2032) & (USD Million)
Table 35. World AI Drug Discovery Market Size by Computational Power, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Drug Discovery Market Size Value by Computational Power (2021-2026) & (USD Million)
Table 37. World AI Drug Discovery Market Size by Computational Power (2027-2032) & (USD Million)
Table 38. World AI Drug Discovery Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Drug Discovery Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI Drug Discovery Market Size by Application (2027-2032) & (USD Million)
Table 41. Recursion Basic Information, Manufacturing Base and Competitors
Table 42. Recursion Major Business
Table 43. Recursion AI Drug Discovery Product and Services
Table 44. Recursion AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Recursion Recent Developments/Updates
Table 46. Recursion Competitive Strengths & Weaknesses
Table 47. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 48. Insilico Medicine Major Business
Table 49. Insilico Medicine AI Drug Discovery Product and Services
Table 50. Insilico Medicine AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Insilico Medicine Recent Developments/Updates
Table 52. Insilico Medicine Competitive Strengths & Weaknesses
Table 53. Schr?dinger Basic Information, Manufacturing Base and Competitors
Table 54. Schr?dinger Major Business
Table 55. Schr?dinger AI Drug Discovery Product and Services
Table 56. Schr?dinger AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Schr?dinger Recent Developments/Updates
Table 58. Schr?dinger Competitive Strengths & Weaknesses
Table 59. DeepMind Basic Information, Manufacturing Base and Competitors
Table 60. DeepMind Major Business
Table 61. DeepMind AI Drug Discovery Product and Services
Table 62. DeepMind AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. DeepMind Recent Developments/Updates
Table 64. DeepMind Competitive Strengths & Weaknesses
Table 65. Insitro Basic Information, Manufacturing Base and Competitors
Table 66. Insitro Major Business
Table 67. Insitro AI Drug Discovery Product and Services
Table 68. Insitro AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Insitro Recent Developments/Updates
Table 70. Insitro Competitive Strengths & Weaknesses
Table 71. Generate Biomedicines Basic Information, Manufacturing Base and Competitors
Table 72. Generate Biomedicines Major Business
Table 73. Generate Biomedicines AI Drug Discovery Product and Services
Table 74. Generate Biomedicines AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Generate Biomedicines Recent Developments/Updates
Table 76. Generate Biomedicines Competitive Strengths & Weaknesses
Table 77. XtalPi Basic Information, Manufacturing Base and Competitors
Table 78. XtalPi Major Business
Table 79. XtalPi AI Drug Discovery Product and Services
Table 80. XtalPi AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. XtalPi Recent Developments/Updates
Table 82. XtalPi Competitive Strengths & Weaknesses
Table 83. Relay Therapeutics Basic Information, Manufacturing Base and Competitors
Table 84. Relay Therapeutics Major Business
Table 85. Relay Therapeutics AI Drug Discovery Product and Services
Table 86. Relay Therapeutics AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Relay Therapeutics Recent Developments/Updates
Table 88. Relay Therapeutics Competitive Strengths & Weaknesses
Table 89. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 90. BenevolentAI Major Business
Table 91. BenevolentAI AI Drug Discovery Product and Services
Table 92. BenevolentAI AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. BenevolentAI Recent Developments/Updates
Table 94. BenevolentAI Competitive Strengths & Weaknesses
Table 95. Roivant Sciences Basic Information, Manufacturing Base and Competitors
Table 96. Roivant Sciences Major Business
Table 97. Roivant Sciences AI Drug Discovery Product and Services
Table 98. Roivant Sciences AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Roivant Sciences Recent Developments/Updates
Table 100. Roivant Sciences Competitive Strengths & Weaknesses
Table 101. Ginkgo Bioworks Basic Information, Manufacturing Base and Competitors
Table 102. Ginkgo Bioworks Major Business
Table 103. Ginkgo Bioworks AI Drug Discovery Product and Services
Table 104. Ginkgo Bioworks AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Ginkgo Bioworks Recent Developments/Updates
Table 106. Ginkgo Bioworks Competitive Strengths & Weaknesses
Table 107. Exscientia Basic Information, Manufacturing Base and Competitors
Table 108. Exscientia Major Business
Table 109. Exscientia AI Drug Discovery Product and Services
Table 110. Exscientia AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Exscientia Recent Developments/Updates
Table 112. Exscientia Competitive Strengths & Weaknesses
Table 113. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 114. Merck KGaA Major Business
Table 115. Merck KGaA AI Drug Discovery Product and Services
Table 116. Merck KGaA AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Merck KGaA Recent Developments/Updates
Table 118. Merck KGaA Competitive Strengths & Weaknesses
Table 119. Novartis Basic Information, Manufacturing Base and Competitors
Table 120. Novartis Major Business
Table 121. Novartis AI Drug Discovery Product and Services
Table 122. Novartis AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Novartis Recent Developments/Updates
Table 124. Novartis Competitive Strengths & Weaknesses
Table 125. Biotus Basic Information, Manufacturing Base and Competitors
Table 126. Biotus Major Business
Table 127. Biotus AI Drug Discovery Product and Services
Table 128. Biotus AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Biotus Recent Developments/Updates
Table 130. Biotus Competitive Strengths & Weaknesses
Table 131. Huazhi Bio Basic Information, Manufacturing Base and Competitors
Table 132. Huazhi Bio Major Business
Table 133. Huazhi Bio AI Drug Discovery Product and Services
Table 134. Huazhi Bio AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Huazhi Bio Recent Developments/Updates
Table 136. Huazhi Bio Competitive Strengths & Weaknesses
Table 137. MindRank AI Basic Information, Manufacturing Base and Competitors
Table 138. MindRank AI Major Business
Table 139. MindRank AI AI Drug Discovery Product and Services
Table 140. MindRank AI AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. MindRank AI Recent Developments/Updates
Table 142. MindRank AI Competitive Strengths & Weaknesses
Table 143. Ubigene Basic Information, Manufacturing Base and Competitors
Table 144. Ubigene Major Business
Table 145. Ubigene AI Drug Discovery Product and Services
Table 146. Ubigene AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Ubigene Recent Developments/Updates
Table 148. Ubigene Competitive Strengths & Weaknesses
Table 149. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 150. WuXi AppTec Major Business
Table 151. WuXi AppTec AI Drug Discovery Product and Services
Table 152. WuXi AppTec AI Drug Discovery Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. WuXi AppTec Recent Developments/Updates
Table 154. WuXi AppTec Competitive Strengths & Weaknesses
Table 155. Global Key Players of AI Drug Discovery Upstream (Raw Materials)
Table 156. Global AI Drug Discovery Typical Customers
LIST OF FIGURES
Figure 1. AI Drug Discovery Picture
Figure 2. World AI Drug Discovery Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Drug Discovery Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Drug Discovery Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Drug Discovery Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 13. AI Drug Discovery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Drug Discovery Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Drug Discovery by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Discovery Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Discovery Markets in 2025
Figure 27. United States VS China: AI Drug Discovery Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Drug Discovery Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Drug Discovery Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Drug Discovery Market Size Market Share by Type in 2025
Figure 31. Machine Learning Type
Figure 32. Deep Learning Type
Figure 33. Natural Language Processing Type
Figure 34. Data Mining Type
Figure 35. World AI Drug Discovery Market Size Market Share by Type (2021-2032)
Figure 36. World AI Drug Discovery Market Size by Drug Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World AI Drug Discovery Market Size Market Share by Drug Type in 2025
Figure 38. Small Molecule Drugs
Figure 39. Biomacromolecules
Figure 40. Novel Therapies
Figure 41. World AI Drug Discovery Market Size Market Share by Drug Type (2021-2032)
Figure 42. World AI Drug Discovery Market Size by Computational Power, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI Drug Discovery Market Size Market Share by Computational Power in 2025
Figure 44. High-Performance Computing Type
Figure 45. Cloud Computing Type
Figure 46. Edge Computing Type
Figure 47. World AI Drug Discovery Market Size Market Share by Computational Power (2021-2032)
Figure 48. World AI Drug Discovery Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World AI Drug Discovery Market Size Market Share by Application in 2025
Figure 50. Target Discovery and Validation
Figure 51. Virtual Screening and Molecular Docking
Figure 52. Drug Repurposing and Precision Medicine
Figure 53. Clinical Data Analysis and Optimization
Figure 54. World AI Drug Discovery Market Size Market Share by Application (2021-2032)
Figure 55. AI Drug Discovery Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. AI Drug Discovery Picture
Figure 2. World AI Drug Discovery Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Drug Discovery Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Drug Discovery Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Drug Discovery Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Drug Discovery Revenue (2021-2032) & (USD Million)
Figure 13. AI Drug Discovery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Drug Discovery Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Drug Discovery by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Discovery Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Discovery Markets in 2025
Figure 27. United States VS China: AI Drug Discovery Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Drug Discovery Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Drug Discovery Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Drug Discovery Market Size Market Share by Type in 2025
Figure 31. Machine Learning Type
Figure 32. Deep Learning Type
Figure 33. Natural Language Processing Type
Figure 34. Data Mining Type
Figure 35. World AI Drug Discovery Market Size Market Share by Type (2021-2032)
Figure 36. World AI Drug Discovery Market Size by Drug Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World AI Drug Discovery Market Size Market Share by Drug Type in 2025
Figure 38. Small Molecule Drugs
Figure 39. Biomacromolecules
Figure 40. Novel Therapies
Figure 41. World AI Drug Discovery Market Size Market Share by Drug Type (2021-2032)
Figure 42. World AI Drug Discovery Market Size by Computational Power, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI Drug Discovery Market Size Market Share by Computational Power in 2025
Figure 44. High-Performance Computing Type
Figure 45. Cloud Computing Type
Figure 46. Edge Computing Type
Figure 47. World AI Drug Discovery Market Size Market Share by Computational Power (2021-2032)
Figure 48. World AI Drug Discovery Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World AI Drug Discovery Market Size Market Share by Application in 2025
Figure 50. Target Discovery and Validation
Figure 51. Virtual Screening and Molecular Docking
Figure 52. Drug Repurposing and Precision Medicine
Figure 53. Clinical Data Analysis and Optimization
Figure 54. World AI Drug Discovery Market Size Market Share by Application (2021-2032)
Figure 55. AI Drug Discovery Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
